Eric Trachtenberg, SEE REMARKS at Kala Pharmaceuticals, Inc. (KALA), sold 2,452 shares at $5.77 ($14K) on 2021-06-28, disclosed to the SEC on 2021-06-29.
Scheduled sale ($14k) by SEE REMARKS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| KALA | SELL | 2022-10-28 | $1K | — | Filing → |
| KALA | SELL | 2022-06-29 | $967 | — | Filing → |
| KALA | SELL | 2022-01-05 | $4K | — | Filing → |